Axios

The DeepMind Institute launched Wednesday seeks to provide a forum for Google, DeepMind and outside researchers to tackle the biggest questions around artificial general intelligence's impacts on society, according to an announcement shared with Axios.

Why it matters: The institute — led by Shane Legg as Managing Editor alongside Google SVP James Manyika and DeepMind Chair Demis Hassabis — aims to make complex academic research accessible to the public and highlight the diversity of perspectives.

Anthropic on Wednesday debuted Claude Docs, bringing Claude closer to everyday knowledge work and raising the stakes for Microsoft, whose venerable Office suite has weathered generations of competition.

Why it matters: The move shows how frontier labs continue to release products that compete with established software giants and startups alike, underscoring why some companies see them as a looming competitive threat.

Wayve spent nearly a decade developing a radically different approach to self-driving cars that others ridiculed but then eventually copied. Now comes the harder part: turning it into a business.

Why it matters: As the British startup moves from R&D to commercialization, it's pursuing an equally unconventional business model — licensing its autonomous-driving AI to automakers and fleet operators rather than building cars or running its own robotaxi network.

Sen. Elizabeth Warren (D-Mass.) is the latest prominent Democrat to back a pause on advanced artificial intelligence, her office told Axios exclusively.

Why it matters: The idea of slowing down AI development — once considered a nonstarter in a fierce race to beat China — is gaining momentum.

Top media leaders across print, digital and broadcast warned about AI's impacts on journalism at the inaugural Status Summit last week.

Why it matters: News publishers recognize that they need to embrace AI to survive the transition to an agentic web, but they refuse to broker deals with companies they feel are illegally scraping their content.

Curing disease is one of AI's most tantalizing use cases, fetching billions of VC dollars, but thus far it's generated more excitement than evidence.

• That's the thrust of a peer-reviewed paper published in Nature Reviews Drug Discovery, which calls the clinical impact of AI "disappointingly limited."

The big picture: The researchers find that while AI has gotten good at identifying drug candidates, it hasn't done much to prove those predictions will survive the complexity of human biology.

Self-driving tech company May Mobility has reached a deal to go public via a merger with a SPAC affiliated with Atlas Credit Partners.

Why it matters: The deal is a test of public-market appetite for autonomous vehicle companies, with May pitching investors on a relatively capital-light alternative to the fleet-owning robotaxi model.

If rising interest rates are stock market kryptonite, investors are confronting a big chunk of that otherworldly mineral right now.

The big picture: The yield on the 10-year Treasury note, seen as the most important interest rate in the world, has hit its highest level — 5.04% — since 2007.

• This means that the price of money has gone up for everyone from the middle-class homebuyer to the behemoth corporation.

Autonomy specialist Swarmer is buying ground-robotics company Ratel for as much as $224 million in a mix of cash and stock.

Why it matters: This international deal signals two things, one in the boardroom and one on the battlefield:

1. Defense industry consolidation is afoot. Not every startup can or will stand on its own.
2. And a world where machines launch machines to fight other machines doing the same, while humans scheme offscreen, has already arrived.

Embraer wants to grow its Middle East customer base on the heels of a deal with the United Arab Emirates for up to 20 C-390 Millenniums.

The big picture: The Brazilian company is racking up buyers across the world for its transporter and refueler.